Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
ReGelTec, a US-based chronic back pain treatment technology spinout of Rowan University, collected more than $3.8m in series A funding on Wednesday from undisclosed investors. The spinout’s technology percutaneously injects therapeutic hydrogels into the nucleus of shattered spinal discs in order to alleviate pain. ReGelTec will put the series A proceeds toward an ongoing feasibility study of its approach in the run-up to clinical trials. It had already raised $2m from investment firm Tedco, Abell Foundation and angel investors in late 2018, according to Technical.ly.
Nextflow Software, a France-based computer-aided engineering software spinout of technical institute Centrale Nantes, has collected €3m ($3.5m) of series A equity funding and debt. The round is made up of $2.4m in debt from state-owned investment bank Bpifrance and regional development bank CIC Ouest, and a $1.2m equity contribution from VC fund Ouest Ventures III and investment fund Litto Invest.
BIOND Solutions, a Netherlands-based cell cultivation microchip technology spinout of TU Delft, has raised €250,000 ($294,000) of growth capital from Uniiq, an EU-backed proof-of-concept fund for the South Holland province. The funding will go toward a recruitment drive. BIOND Solutions’ microchip would supply oxygen and nutrients to human cells as the basis for creating personalised medicines.